TSRF Blog

 

Secrets of Nutrition
& Sports Supplements
Revealed

 

 

 

 

 

Research Articles

 

Coleus Forskohlii (forskolin)

 

Acta Diabetol Lat 1991 Jan-Mar;28(1):71-7

 

Insulin and glucagon releasing activity of coleonol (forskolin) and its effect on blood glucose level in normal and alloxan diabetic rats.

Ahmad F, Khan MM,
Rastogi AK, Kidwai JR.

Division of Biochemistry, Central Drug Research Institute, Lucknow, India.

Colenol, a diterpenoid isolated from the roots of Coleus forskohlii stimulates the release of insulin and glucagon from the islets both in vitro and in vivo. Colenol-stimulated release of glucagon from islets in vitro is much more pronounced as compared to that of insulin. Glucose concentration of 5.6 mM in the medium is required for the colenol stimulation of insulin release. Feeding of coleonol to alloxan diabetic rats cause 36.5% increase in blood glucose level as compared to alloxan diabetic control. Oral feeding of coleonol for 7 days to normal rats causes increase in blood glucose, serum insulin, glucagon and free fatty acid levels with corresponding increase in glucose-6-phosphatase activity and depletion of liver glycogen. Predominant stimulation of A-cells by coleonol is suggested for the above effects.

 

Arzneimittelforschung 1981;31(8):1248-50

 

The positive inotropic-acting forskolin, a potent adenylate cyclase activator.

Metzger H, Lindner E.

Forskolin is a positive inotropic-acting and blood pressure lowering agent which was isolated from the Indian plant Coleus forskohlii. In isolated heart tissue, forskolin activates a membrane bound adenylatecyclase and a cytoplasmic cAMP-dependent protein kinase to a much higher degree than does isoprenaline. This activation does not require the hormone receptor. In isolated and electrically stimulated left guinea pig atria, the adenylate-cyclase activation by forskolin is the prerequisite for the positive inotropic effect. We therefore postulate the adenylatecyclase activation to be correlated with the positive inotropic effect via an enhanced calcium uptake by the heart muscle cell.

 

J Ethnopharmacol 1981 Jan;3(1):1-13

Related Articles, Links


Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii.

Dubey MP, Srimal RC, Nityanand S, Dhawan BN.

Coleus spp. have been used in Aurvedic medicine for heart diseases, spasmodic pain, painful micturition and convulsions. The pharmacological properties of coleonol, a diterpene, isolated from Coleus forskohlii were investigated. Its predominant effect is to lower the blood pressure of anaesthetised cat and rat as well as of the spontaneously hypertensive rat due to relaxation of the vascular smooth muscle. In small doses it has a positive inotropic effect on isolated rabbit heart as well as on cat heart in vivo. Coleonol also exhibits nonspecific spasmolytic activity on smooth muscle of the gastrointestinal tract in various species but not on bronchial musculature of guinea pig. Large doses of coleonol have a depressant action on the central nervous system. These results provide the rationale for the use of this plant in Aurvedic medicine. 

 

Trends Pharmacol Sci 1989 Nov;10(11):442-7

 

Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action?

Laurenza A, Sutkowski EM, Seamon KB.

Forskolin, a naturally occurring diterpene, directly stimulates adenylyl cyclase and has been used extensively to increase cAMP and to elicit cAMP-dependent physiological responses. More recently, forskolin has been shown to inhibit a number of membrane transport proteins and channel proteins through a mechanism that does not involve the production of cAMP. Many of these channel proteins are predicted to have similar topographies in the membrane bilayer and it is tempting to speculate that forskolin may be binding at structurally homologous sites. Kenneth Seamon and colleagues discuss the cAMP-independent effects of forskolin and the structural similarity between forskolin and other physiologically important substances such as hexoses and steroids with respect to potential forskolin binding sites.

  

Endocrinology 1982 Sep;111(3):849-56

 

Forskolin stimulation of thyroid adenylate cyclase and cyclic 3',5'-adenosine monophosphate accumulation.

Fradkin JE, Cook GH, Kilhoffer MC, Wolff J.

The diterpene forskolin is a potent (100-fold) stimulator of guinea pig thyroid cAMP accumulation with half-maximal activation occurring at 40 microM. Forskolin stimulation is more rapid than that of TSH, attaining a 5-fold increase within 1 min of exposure. The stimulation is also rapidly reversible. The diterpene does not sensitize thyroid cAMP accumulation to TSH, and the concentration yielding half-maximal response is not altered by the presence of low levels of forskolin. At maximally stimulating concentrations, the effects of TSH and forskolin on cAMP accumulation are additive. Forskolin stimulates thyroid adenylate cyclase approximately 10-fold in membranes from several species with half-maximal effects occurring at 3--9 microM through an action on the maximum velocity and not the Km for ATP. The activation of thyroid membranes is readily reversible. Guanyl nucleotides are not required for stimulation by forskolin, and they do not sensitize to forskolin. Moreover, the drug did not sensitize the membrane adenylate cyclase to guanosine 5'-[beta, gamma-imido]triphosphate or to isoproterenol and was equally effective with either Mg++ or Mn++ as the divalent cation. Forskolin stimulation is additive with that of guanyl nucleotides and F-. The site of action of forskolin in the adenylate cyclase complex is uncertain. Data from Bordetella pertussis, testicular, and S-49 lymphoma mutant cyclases suggest that one of the guanyl nucleotide regulatory proteins may be required to promote the forskolin effect. We conclude that forskolin is a useful activator of thyroid adenylate cyclase both in vitro and in intact tissue, which will be useful in elucidating the coupling process of the adenylate cyclase system and in differentiating cAMP-mediated from other forms of activation of the thyroid.

  

Acta Endocrinol (Copenh) 1985 Feb;108(2):200-5

 

Forskolin stimulation of adenylate cyclase in human thyroid membranes.

Kasai K, Suzuki Y, Hiraiwa M, Kuroda H, Emoto T, Nakamura T, Shimoda S.

Forskolin stimulates adenylate cyclase in human thyroid membranes approximately 7-fold with half-maximal stimulation occurring at 5-10 microM. Guanine nucleotides are not required for stimulation of the enzyme by forskolin. Forskolin-stimulation is additive or greater than additive with that of TSH or Gpp(NH)p- (above 1 microM). Different from TSH- or Gpp(NH)p-stimulation of adenylate cyclase, uncoupling of the guanine nucleotide-binding regulatory component by increasing concentrations of MnCl2 did not result in uncoupling of forskolin stimulation. The finding indicates that forskolin may mainly act on the catalytic component of adenylate cyclase. From the present study, it is suggested that the diterpene forskolin stimulates adenylate cyclase in human thyroid membranes by a novel mechanism that differs from TSH- or Gpp(NH)p-stimulation, and that the diterpene may be a useful tool to investigate the metabolism of thyroid and its regulation in normal and pathological situations.

 

 

Back to Research Page

 

 

 

© 2002-2005 Supplement Research Foundation, Inc. All rights reserved.

The content on this site is for informational purposes only and does not replace the advice of a qualified physician.

Please consult a doctor before starting any nutrition, training, and supplementation program.